Recanalization and stroke outcome

Circulation

Volumn 115, Issue 20, 2007, Pages 2602-2605

  Del Zoppo, Gregory J ^a   Koziol, James A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Angiography; Cerebrovascular circulation; Editorials; Reperfusion; Stroke; Ultrasonics

Indexed keywords

ALTEPLASE; PLACEBO;

BRAIN ANGIOGRAPHY; BRAIN ARTERY; CLINICAL TRIAL; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; EDITORIAL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MIDDLE CEREBRAL ARTERY; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RATING SCALE; RECANALIZATION; SCORING SYSTEM; STROKE; TREATMENT OUTCOME;

BRAIN ISCHEMIA; CAROTID STENOSIS; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; NEUROPSYCHOLOGICAL TESTS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 34249010803     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.698225     Document Type: Editorial

References (29)

1. del Zoppo GJ, Zeumer H, Harker LA. Thrombolytic therapy in stroke: possibilities and hazards. Stroke. 1986;17:595-607.
2. del Zoppo GJ, Ferbert A, Otis S, Brückmann H, Hacke W, Zyroff J, Harker LA, Zeumer H. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: a pilot study. Stroke. 1988;19:307-313.
3. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R Jr, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
4. Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology. 1992;42: 976-982.
5. Yamaguchi T, Hayakawa T, Kikuchi H. Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis. 1993;3:269-272.
6. Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP, Pessin MS, Bleich HL. The Harvard Cooperative Stroke Registry: a prospective registry of patients hospitalized with stroke. Neurology. 1978; 28:754-762.
7. Mikulik R, Ribo M, Hill MD, Grotta JC, Malkoff M, Molina C, Rubiera M, Delgado-Mederos R, Alvarez-Sabin J, Alexandrov AV; for the CLOTBUST Investigators. Accuracy of serial National Institutes of Health Stroke Scale scores to identify artery status in acute ischemic stroke. Circulation. 2007;115:2660-2665.
8. Alexandrov AV, Demchuk AM, Burgin WS, Robinson DJ, Grotta JC, for the CLOTBUST Investigators. Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I: findings of the CLOTBUST trial. J Neuroimaging. 2004;14:113-117.
9. Alexandrov AV, Wojner AW, Grotta JC, for the CLOTBUST Investigators. CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke. J Neuroimaging. 2004;14: 108-112.
10. Zanette EM, Fieschi C, Bozzao L, Roberti C, Toni D, Argentino C, Lenzi GL. Comparison of cerebral angiography and transcranial Doppler sonography in acute stroke. Stroke. 1989;20:899-903.
11. Camerlingo M, Casto L, Censori B, Ferraro B, Gazzaniga GC, Mamoli A. Transcranial Doppler in acute ischemic stroke of the middle cerebral artery territories. Acta Neurol Scand. 1993;88:108-111.
12. Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci. 1989;91:311-321.
13. Baumgartner RW, Mattle HP, Schroth G. Assessment of ≥50% and <50% intracranial stenoses by transcranial color-coded duplex sonography. Stroke. 1999;30:87-92.
14. Demchuk AM, Christou I, Wein TH, Felberg RA, Malkoff M, Grotta JC, Alexandrov AV. Accuracy and criteria for localizing arterial occlusion with transcranial Doppler. J Neuroimaging. 2000;10:1-12.
15. Christou I, Felberg RA, Demchuk AM, Burgin WS, Malkoff M, Grotta JC, Alexandrov AV. Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging. 2002;12:119-123.
16. Burgin WS, Malkoff M, Felberg RA, Demchuk AM, Christou I, Grotta JC, Alexandrov AV. Transcranial Doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. Stroke. 2000;31:1128-1132.
17. Saqqur M, Shuaib A, Alexandrov AV, Hill MD, Calleja S, Tomsick T, Broderick J, Demchuk AM. Derivation of transcranial Doppler criteria for rescue intra-arterial thrombolysis: multicenter experience from the Interventional Management of Stroke study. Stroke. 2005;36:865-868.
18. Alexandrov AV, Sloan MA, Wong LK, Douville C, Razumovsky AY, Koroshetz WJ, Kaps M, Tegeler CH. Practice standards for transcranial Doppler ultrasound: part I: test performance. J Neuroimaging. 2007;17: 11-18.
19. De Haan R, Horn J, Limburg M, Van Der Meulen J, Bossuyt P. A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke. 1993;24:1178-1181.
20. Wityk RJ, Pessin MS, Kaplan RF, Caplan LR. Serial assessment of acute stroke using the NIH stroke scale. Stroke. 1994;25:362-365.
21. Adams HPJ, Davis PH, Leira EC, Chang BH, Bendixen WR, Clarke RF, Woolson, Hansen MD. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999;53:126-131.
22. Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, Broderick JP, Lewandowski CA, Marler JR, Levine SR, Brott T. Effects of tissue plasminogen activator for acute ischemic stroke at one year: National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med. 1999;340:1781-1787.
23. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von KR, Boysen G, Bluhmki E, Hoxter G, Mahagne MH. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995; 274:1017-1025.
24. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P, for the Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352:1245-1251.
25. Koziol JA, Feng AC. On the analysis and interpretation of outcome measures in stroke clinical trials: lessons from the SAINT I study of NXY-059 for acute ischemic stroke. Stroke. 2006;37:2644-2647.
26. Koziol JA, Hacke W. Multivariate data reduction by principal components, with application to neurological scoring instruments. J Neurol. 1990;237:461-464.
27. Koziol JA, Frutos A, Sipe JC, Romine JS, Beutler E. A comparison of two neurologic scoring instruments for multiple sclerosis. J Neurol. 1996;243: 209-213.
28. Sipe JC, Knobler RL, Braheny SL, Rice GP, Panitch HS, Oldstone MB. A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology. 1984;34:1368-1372.
29. Koziol JA, Lucero A, Sipe JC, Romine JS, Beutler E. Responsiveness of the Scripps neurologic rating scale during a multiple sclerosis clinical trial. Can J Neurol Sci. 1999;26:283-289.